▽The New England Journal of Medicine: Research & Review Articles on Diseases & Clinical Practice ●04/18 05:24 Feb 07, 2025CMEObinutuzumab in Active Lupus NephritisR.A. Furie and OthersIn this trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis.Editorial To B or Not to B — the Role of B-Cell Depletion in Lupus NephritisImages in Clinical MedicineApr 12,
▽Journal of Clinical Oncology ●04/17 22:43 ORIGINAL REPORTS Apr 16, 2025Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834Satoru Miura et al.Partial AccessEDITORIALS Apr 16, 2025Can Improving Adjuvant Endocrine Therapy Persistence Improve Survival Outcomes for Patients With Early-Stage Breast Cancer?Megan E.
▽The Oncologist ●10/01 08:08 NEW USER > INSTITUTIONAL LOGIN > Too Short Weak Medium Strong Very Strong Too Long Please check your email for instructions on resetting your password. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new Wiley Online Library account.
